Infringement Analysis in Uppsala.

A patent infringement analysis Uppsala rights-holders can rely on has to be built for the way Sweden actually proves infringement — through a court-ordered infringement investigation rather than US-style discovery, before a single nationally concentrated specialist court, and, for European patents, alongside a pan-European route seated just down the E4 in Stockholm. Uppsala is one of Europe’s densest life-science clusters: more than a hundred companies within a ten-kilometre radius, anchored by Cytiva — the city’s largest private employer, with roots in Pharmacia Biotech and GE Healthcare — alongside Fresenius Kabi, Thermo Fisher’s Phadia, Galderma’s Q-Med line, Biotage and the research base of Uppsala University and SLU. Yet no patent case is tried in Uppsala itself: since 1 September 2016 Sweden reserves every patent infringement and validity action to the Patent and Market Court within the Stockholm District Court. That concentration, combined with Sweden’s infringement investigation and its membership of the Unified Patent Court, gives an Uppsala portfolio owner a distinctive set of levers. PerspireIP builds the element-by-element claim charts and dated evidence-of-use that a Patent and Market Court judge, a UPC panel and an enforcement expert can adopt.

Where a patent infringement analysis Uppsala case is heard

Sweden does not spread patent litigation across its regional courts. Since a reform that took effect on 1 September 2016, all patent infringement and validity actions are concentrated in a single specialist forum: the Patent and Market Court (Patent- och marknadsdomstolen), which sits within the Stockholm District Court. An Uppsala-based biopharma manufacturer, diagnostics developer or medtech company therefore litigates its patents in Stockholm, not in the Uppsala tingsrätt. Appeals run to the Patent and Market Court of Appeal (Patent- och marknadsöverdomstolen), which sits within the Svea Court of Appeal, so both instances are heard by the same specialised bench.

The distance is short — roughly seventy kilometres — but the point is strategic, not geographic. Infringement and invalidity are formally separate cases in Sweden, yet the same court decides both, and at a party’s request they can be joined or split. That means an infringement analysis prepared for an Uppsala patentee has to anticipate a validity counterattack from the outset, because the judge weighing infringement is the same judge who will weigh the prior art. A tightly built, independently verifiable evidence file is what carries weight before a concentrated specialist bench that sees the country’s entire patent docket.

• Patent and Market Court — the single first-instance court, within the Stockholm District Court, with exclusive national jurisdiction over Swedish patent infringement and validity actions since 1 September 2016
• Patent and Market Court of Appeal — within the Svea Court of Appeal, reviewing first-instance patent judgments before the same specialised forum
• No Uppsala forum — despite the city’s research weight, no patent case is tried in Uppsala itself; the analysis must be built for Stockholm
• Joined or split — infringement and validity are separate cases but decided by the same court, and can be tried together or apart at a party’s request

The infringement investigation: how Sweden proves infringement

Sweden has no US-style pre-trial discovery. The concept that comes closest is the infringement investigation (intrångsundersökning), a court-ordered search-and-preservation measure introduced to meet the TRIPS Agreement. A patent owner or licensee that can show probable cause for infringement can obtain a court order allowing access to the alleged infringer’s premises to search for and secure evidence of the accused product or process. The order is executed by the Swedish Enforcement Authority (Kronofogden), and a rule of proportionality governs how far the measure may reach.

For Uppsala’s bioprocess and diagnostics companies this is decisive. Infringement of a chromatography-resin claim, a cell-culture-media formulation, a surface-plasmon-resonance assay or a bioreactor control method is rarely visible from the outside; it lives in recipes, process parameters, batch records and instrument firmware. The infringement investigation is the mechanism that can put those facts on the record before trial — but only if the underlying claim mapping is convincing enough to clear the probable-cause threshold and survive the proportionality check. A rights-holder can also apply for an order to disclose information about the origin and distribution of infringing goods, widening the evidentiary picture.

• Infringement investigation / intrångsundersökning — a court-ordered search to secure evidence before trial, Sweden’s functional substitute for discovery
• Enforcement Authority (Kronofogden) — executes the court’s search-and-seizure order at the alleged infringer’s premises
• Probable cause & proportionality — the applicant must show a credible infringement case, and the measure is limited to what is proportionate
• Disclosure of information — a separate order can compel details of the origin and distribution channels of infringing products

This is why a patent infringement analysis Uppsala parties commission cannot stop at a tidy conclusion. It has to justify the investigation to a sceptical judge, predict what the search will bring back, and be written so that the material recovered maps cleanly onto every claim limitation.

Sweden in the UPC: the Nordic-Baltic Regional Division

Sweden is a full member of the Unified Patent Court (UPC), live since 1 June 2023, and it hosts the Nordic-Baltic Regional Division, seated in Stockholm and covering Sweden, Estonia, Latvia and Lithuania. So for a European patent that has not been opted out, a second, pan-European route runs alongside the national Swedish one. A UPC judgment reaches across every participating member state at once, which changes the calculus for an Uppsala patentee weighing a purely Swedish action before the Patent and Market Court against a continent-wide injunction covering the single market its exports serve.

The Nordic-Baltic division has one feature no other UPC division shares: English is its sole language of proceedings. That is a natural fit for Uppsala’s internationally staffed life-science employers, whose technical documentation and expert witnesses already work in English. The strategic fork is the opt-out. During the transitional period a proprietor can remove a classic European patent from the UPC’s jurisdiction, keeping enforcement in the national Stockholm court alone; leaving the patent in play opens the UPC route but also exposes it to a single central revocation. Whether to opt out, and which forum to enforce in, is a decision the infringement analysis has to inform rather than assume.

• National route — the Patent and Market Court in Stockholm for Swedish patents and validated European patents kept out of the UPC
• UPC route — infringement and revocation of non-opted-out European patents and unitary patents, with pan-European effect, before the Nordic-Baltic Regional Division or a central division
• English only — the Nordic-Baltic Regional Division conducts proceedings solely in English, unique among UPC divisions
• Opt-out choice — the decision to keep a European patent in or out of the UPC shapes the forum, the reach of any injunction and the exposure to central revocation

Uppsala’s docket: bioprocess, diagnostics, formulation and materials

Uppsala’s patent docket is written by its life-science economy, one of the most concentrated in Europe: more than a hundred companies with a combined turnover in the tens of billions of kronor, nearly all within ten kilometres. The anchor is Cytiva — formerly GE Healthcare Life Sciences, before that Pharmacia Biotech — the city’s largest private employer and a world leader in bioprocess and separation technology: chromatography resins, filtration media, cell-culture media and single-use systems. This is the birthplace of the Biacore surface-plasmon-resonance platform, so label-free biosensing and assay patents sit at the heart of the local docket. These claims are proven from process parameters, resin and media chemistry and instrument behaviour — precisely the material an infringement investigation is designed to capture.

Around Cytiva sits a dense field of specialists. Fresenius Kabi and Recipharm drive formulation, sterile-fill and drug-delivery claims; Thermo Fisher’s Phadia centres in-vitro diagnostics and allergy testing; Galderma’s Q-Med heritage brings hyaluronic-acid and aesthetic-medicine chemistry; Biotage covers separation and purification instruments. The research base of Uppsala University and the Swedish University of Agricultural Sciences (SLU), clustered in Uppsala Science Park and Uppsala Business Park, adds diagnostics, materials science, agri-biotech and cleantech spin-outs. Each writes its own claim-mapping demands, and each frequently carries a supplementary protection certificate (SPC) extending a pharmaceutical or agrochemical patent.

• Bioprocess & separation — chromatography-resin, filtration-media, cell-culture-media and single-use-system claims, mapped from process parameters and chemistry secured by an infringement investigation
• Diagnostics & biosensing — surface-plasmon-resonance, immunoassay and in-vitro-diagnostic claims from the Biacore and Phadia lineage, proven from instrument behaviour and assay chemistry
• Formulation & drug delivery — sterile-fill, formulation, hyaluronic-acid and delivery-device claims from the pharma and aesthetics cluster, often paired with an SPC
• Materials, agri-biotech & cleantech — university and SLU spin-out claims proven from deployed product, process data and analytical records

Building claim charts and evidence-of-use for a Swedish or UPC forum

The specialised Patent and Market Court, the Enforcement Authority executing an investigation, and the UPC’s technically qualified panels all expect a disciplined evidentiary file — a chart that can be independently verified rather than merely argued. We start from claim construction, working through the claims, the specification and the prosecution history, then map each limitation against the real accused product and process, literally and, where appropriate, under the doctrine of equivalents as applied in Sweden.

• Element-by-element claim charts tying every limitation to a documented, dated piece of evidence an enforcement expert can re-run
• Bioprocess and separation evidence-of-use from resin and media chemistry, process parameters, chromatography and filtration performance and batch records
• Diagnostics evidence-of-use from teardown and analysis of biosensing and immunoassay instruments and their assay chemistry
• Formulation and drug-delivery evidence-of-use from reverse formulation, sterile-fill process data and regulatory records, with SPC scope mapped where relevant
• Non-infringement and design-around positions for an accused party, anchored to the specification and the file wrapper
• A coordinated invalidity file, because a validity challenge runs alongside the infringement action in Stockholm and at the UPC

The deliverable is scoped to the forum. A national action before the Patent and Market Court, a Swedish infringement-investigation application, or a UPC infringement or revocation action each demands a slightly different package. What never changes is the core: a claim chart an enforcement expert and a specialist judge can adopt, built on evidence rather than conclusions and strong enough to clear Sweden’s probable-cause threshold.

How PerspireIP scopes an Uppsala infringement-analysis engagement

Every engagement follows the same path. We fix the correct claim construction, map each element against the accused product, and assemble evidence-of-use in the form the technology demands — chemistry and process records for bioprocess and separation, teardown and assay analysis for diagnostics instruments, reverse formulation and regulatory data for pharma and aesthetics. Then we build the file the Swedish process actually uses: material an infringement investigation can secure and an enforcement expert can verify.

• Claim construction and element-by-element charting against a Swedish national patent, a validated European patent or a unitary patent
• Evidence-of-use assembly dated and documented for an infringement investigation, a Patent and Market Court judge or a UPC panel
• Infringement and non-infringement positions built for either side, coordinated with any parallel validity or revocation challenge
• Deliverables scoped to the track — a Stockholm complaint, an infringement-investigation application, or a UPC statement of claim, with the opt-out question flagged early

We work alongside your Swedish and international counsel as a specialist analysis partner, deliver to Patent and Market Court and UPC deadlines, and keep every engagement confidential. Whether you are a bioprocess supplier, a diagnostics developer, a formulation or aesthetics company enforcing a portfolio, an accused party clearing a path to market, or litigation counsel preparing a claim or a defence, we scale to fit — a single claim chart, a multi-patent matter, or ongoing portfolio support. Send us the patent number and the accused product, and we will scope the work within one business day.

IP Landscape & Resources in Uppsala

Key intellectual-property authorities and venues relevant to Uppsala:

• Swedish Intellectual Property Office (PRV) — the Patent- och registreringsverket, Sweden's national authority granting Swedish patents and administering supplementary protection certificates
• Swedish Courts (Patent and Market Court) — the official portal of Sveriges Domstolar; the Patent and Market Court (Patent- och marknadsdomstolen) within the Stockholm District Court holds exclusive national jurisdiction over patent infringement and validity actions, with appeal to the Patent and Market Court of Appeal within the Svea Court of Appeal
• Unified Patent Court (UPC) — the pan-European court that hears infringement and revocation of non-opted-out European patents and unitary patents, with the Nordic-Baltic Regional Division seated in Stockholm covering Sweden, Estonia, Latvia and Lithuania and conducting proceedings solely in English
• European Patent Office (EPO) — the office that grants European patents which, once validated in Sweden or granted unitary effect, are enforced before the Patent and Market Court or the UPC

Request a Patent Infringement Analysis in Uppsala

Explore related PerspireIP services: Patent Infringement Analysis · Prior Art Litigation Search · Patent Invalidation.

Frequently Asked Questions